Clinical Trial Update: PEG3350 in ACLF With Hepatic Encephalopathy [Phase 4]

View source ↗

Summary

Clinical trial update for PEG3350 in acute-on-chronic liver failure with hepatic encephalopathy (Phase 4) is ongoing with an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy
• On Chronic Liver Failure

Drugs mentioned

• PEG3350

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Hepatic Encephalopathy, Acute-On-Chronic Liver Failure | Phase 4 | Status: UNKNOWN